Zacks Investment Management Sc Pharmaceuticals Inc. Transaction History

Zacks Investment Management

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$4.02 - $7.53 $18,383 - $34,434	-4,573 Reduced 12.36%	32,416 $232,000
Q2 2021 Aug 16, 2021	BUY	$5.19 - $7.38 $191,972 - $272,978	36,989 New	36,989 $226,000
Q1 2021 May 17, 2021	SELL	$5.65 - $7.66 $217,745 - $295,208	-38,539 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$5.17 - $9.41 $199,246 - $362,651	38,539 New	38,539 $204,000

37.1M

110K

12.1K

Ticker SCPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 27,402,100
Market Cap $92.9M
Description
scPharmaceuticals Inc., a pharmaceutical company, engages in the development and commercialization of various pharmaceutical products. The company's lead product candidate is FUROSCIX that consists of formulation of furosemide, which is delivered through an on-body infusor for treatment of congestion in patients with heart failure. Its product p...

Get notified when there are updates to the investment portfolio of Zacks Investment Management, based on Form 13F filings with the SEC.

Stay updated on Zacks Investment Management with notifications on news.